Jean Francois Bosset

Summary

Country: France

Publications

  1. ncbi request reprint Neoadjuvant treatment of early stage squamous cell carcinoma of the esophagus
    J F Bosset
    Departments of Radiotherapy, CHU Jean Minjoz, Besancon, France
    Dis Esophagus 15:117-20. 2002
  2. ncbi request reprint Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastr
    J F Bosset
    Radiotherapy Department, Besancon University Hospital, Besancon, France
    Eur J Cancer 39:45-51. 2003
  3. ncbi request reprint Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921
    Jean Francois Bosset
    Centre Hospitalier Universitaire Besançon, France
    J Clin Oncol 23:5620-7. 2005
  4. ncbi request reprint Radiation and chemoradiation therapy for esophageal adenocarcinoma
    Jean Francois Bosset
    Department of Radiation Oncology, Besancon University Hospital, Boulevard Fleming, F 25030 Besancon Cedex, France
    J Surg Oncol 92:239-45. 2005
  5. ncbi request reprint Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group
    J F Bosset
    Besancon University Hospital, Boulevard Fleming, F 25030, Besancon Cedex, France
    Eur J Cancer 40:219-24. 2004
  6. ncbi request reprint Radiation therapy and upper gastrointestinal tract: esophageal, gastric, and pancreatic cancer. Toward new standards?
    J F Bosset
    Department of Radiation Oncology, Besancon University Hospital, Besancon, France
    Curr Opin Oncol 17:377-80. 2005
  7. ncbi request reprint Preoperative radiotherapy in elderly patients with rectal cancer
    Fabrice Lorchel
    service d oncologie radiothérapie, CHU Jean Minjoz, 25030 Besancon Cedex, France
    Gastroenterol Clin Biol 31:436-41. 2007
  8. ncbi request reprint Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial
    Alain Toledano
    Department of Radiation Oncology, Henry Kaplan, Hopital Bretonneau, Tours, France
    J Clin Oncol 25:405-10. 2007
  9. ncbi request reprint Chemotherapy with preoperative radiotherapy in rectal cancer
    Jean Francois Bosset
    Department of Radiation Therapy, University of Franche Comte, Besancon, France
    N Engl J Med 355:1114-23. 2006
  10. ncbi request reprint Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
    Jean Francois Bosset
    Department of Radiation Oncology, Besançon University Hospital J Minjoz, Besancon, France Electronic address
    Lancet Oncol 15:184-90. 2014

Collaborators

Detail Information

Publications23

  1. ncbi request reprint Neoadjuvant treatment of early stage squamous cell carcinoma of the esophagus
    J F Bosset
    Departments of Radiotherapy, CHU Jean Minjoz, Besancon, France
    Dis Esophagus 15:117-20. 2002
  2. ncbi request reprint Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastr
    J F Bosset
    Radiotherapy Department, Besancon University Hospital, Besancon, France
    Eur J Cancer 39:45-51. 2003
    ..The 22953 scheme is feasible and the results are promising. This is now considered as the new standard scheme by the EORTC...
  3. ncbi request reprint Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921
    Jean Francois Bosset
    Centre Hospitalier Universitaire Besançon, France
    J Clin Oncol 23:5620-7. 2005
    ..We investigated the effect of adding CT on the pathologic parameters...
  4. ncbi request reprint Radiation and chemoradiation therapy for esophageal adenocarcinoma
    Jean Francois Bosset
    Department of Radiation Oncology, Besancon University Hospital, Boulevard Fleming, F 25030 Besancon Cedex, France
    J Surg Oncol 92:239-45. 2005
    ....
  5. ncbi request reprint Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group
    J F Bosset
    Besancon University Hospital, Boulevard Fleming, F 25030, Besancon Cedex, France
    Eur J Cancer 40:219-24. 2004
    ..At the doses recommended in the protocol, the addition of 5-FU-LV to preoperative XRT slightly increased the amount of acute toxicity. However, the compliance with the radiation protocol or the feasibility of surgery did not decrease...
  6. ncbi request reprint Radiation therapy and upper gastrointestinal tract: esophageal, gastric, and pancreatic cancer. Toward new standards?
    J F Bosset
    Department of Radiation Oncology, Besancon University Hospital, Besancon, France
    Curr Opin Oncol 17:377-80. 2005
    ..To emphasize the role and place of chemoradiation in the treatment of patients with upper gastrointestinal tract cancer...
  7. ncbi request reprint Preoperative radiotherapy in elderly patients with rectal cancer
    Fabrice Lorchel
    service d oncologie radiothérapie, CHU Jean Minjoz, 25030 Besancon Cedex, France
    Gastroenterol Clin Biol 31:436-41. 2007
    ....
  8. ncbi request reprint Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial
    Alain Toledano
    Department of Radiation Oncology, Henry Kaplan, Hopital Bretonneau, Tours, France
    J Clin Oncol 25:405-10. 2007
    ..This report presents the clinical results with a median follow-up of 60 months...
  9. ncbi request reprint Chemotherapy with preoperative radiotherapy in rectal cancer
    Jean Francois Bosset
    Department of Radiation Therapy, University of Franche Comte, Besancon, France
    N Engl J Med 355:1114-23. 2006
    ..Preoperative radiotherapy is recommended for selected patients with rectal cancer. We evaluated the addition of chemotherapy to preoperative radiotherapy and the use of postoperative chemotherapy in the treatment of rectal cancer...
  10. ncbi request reprint Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
    Jean Francois Bosset
    Department of Radiation Oncology, Besançon University Hospital J Minjoz, Besancon, France Electronic address
    Lancet Oncol 15:184-90. 2014
    ..Adjuvant chemotherapy did not improve survival, but the Kaplan-Meier curves diverged, suggesting possible delayed benefit. Here, we report the updated long-term results...
  11. doi request reprint Feasibility of chemoradiotherapy for oesophageal cancer in elderly patients aged >or=75 years: a prospective, single-arm phase II study
    Stéphanie Servagi-Vernat
    Department of Radiation Therapy, Besancon University Hospital, Besancon, France
    Drugs Aging 26:255-62. 2009
    ..Secondary endpoints were progression-free survival (PFS) and quality of life (QOL)...
  12. ncbi request reprint Tumor volume as outcome determinant in patients treated with chemoradiation for locally advanced esophageal cancer
    Gilles Crehange
    Department of Radiation Oncology, Besancon University Hospital, France
    Am J Clin Oncol 29:583-7. 2006
    ..There is a need for both an efficient, easy-to-perform clinical classification and for identification of pretherapeutic prognostic factors that would be useful for oncologists, one of which is tumor volume...
  13. ncbi request reprint Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
    Michel Bolla
    Department of Radiation Oncology, Centre Hospitalier Universitaire A Michallon, Grenoble, France
    Lancet 380:2018-27. 2012
    ....
  14. ncbi request reprint Combining cisplatin and mitomycin with radiotherapy in anal carcinoma
    Gilles Crehange
    Department of Radiation Oncology, Besancon University Hospital, Besancon, France
    Dis Colon Rectum 50:43-9. 2007
    ..We tested the feasibility of chemoradiation in anal carcinoma with mitomycin and cisplatin in a phase II study...
  15. ncbi request reprint [Locoregional recurrent rectal cancer: the place of radiotherapy]
    Fabrice Lorchel
    Service de Radiotherapie, CHU Jean Minjoz, Besancon
    Bull Cancer 91:833-8. 2004
    ..Actually, multimodal therapy provides the best results for local control and overall survival. Exclusive external radiotherapy is indicated for palliative treatment of unresectable cases of recurrence...
  16. ncbi request reprint Recent advances in the treatment of localized rectal cancer
    Jean Francois Bosset
    Department of Radiation Oncology, Besancon University Hospital, Boulevard Fleming, F 25030 Besancon Cedex, France
    Curr Oncol Rep 10:220-4. 2008
    ....
  17. pmc Determinants of patient satisfaction in ambulatory oncology: a cross sectional study based on the OUT-PATSAT35 questionnaire
    Thanh Vân France Nguyen
    Oncology Radiotherapy Department, Besancon University Hospital, 3 boulevard Fleming, 25030 Besancon, Cedex, France
    BMC Cancer 11:526. 2011
    ..We investigated associations between patients' baseline clinical and socio-demographic characteristics, as well as self-reported quality of life, and satisfaction with care...
  18. ncbi request reprint Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
    Michel Bolla
    Department of Radiation Oncology, Centre Hospitalier Universitaire A Michallon, Grenoble, France
    Lancet 366:572-8. 2005
    ..We did a randomised controlled trial to compare radical prostatectomy followed by immediate external irradiation with prostatectomy alone for patients with positive surgical margin or pT3 prostate cancer...
  19. doi request reprint Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial
    Franck Monnien
    Department of Pathology, Besancon University Hospital, Besancon, France
    J Clin Pathol 63:873-8. 2010
    ..Signal transducer and activator of transcription 3 (STAT3) has been implicated as an oncogene in several neoplastic diseases. However, the biological effects of STAT3 have not been extensively studied in rectal carcinogenesis...
  20. ncbi request reprint Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy
    Alexis Lépinoy
    Lab of Imaging Engineering Le2I, IMAC Core, CNRS UMR 6306, University of Burgundy, Dijon, France Department of Radiation Oncology, University Hospital Jean Minjoz, Besancon, France
    Radiother Oncol 111:120-5. 2014
    ..The purpose of this study was to describe the pattern of nodal relapse with (18)F-fluoro-choline (FCH) Positron Emission Tomography/Computerized Tomography (PET/CT) in prostate cancer patients after radiotherapy...
  21. pmc Defining preoperative treatment strategies in t3 rectal cancer
    Jean Francois Bosset
    Department of Radiation Oncology, Besancon University Hospital, Besancon, France
    Gastrointest Cancer Res 2:S54-7. 2008
    ....
  22. ncbi request reprint [Radiation-induced enteropathy]
    Lucine Vuitton
    Service de Gastroenterologie, CHU Jean Minjoz, 25030 Besancon, France
    Rev Prat 58:1217-22. 2008
    ..Current optimal radiotherapy planning may predict precisely toxicities and new technologies for treatment delivery may prevent and/or reduce the frequency and severity of radiation enteropathy...
  23. ncbi request reprint Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views
    Alain H Toledano
    Department of Radiation Oncology, Hopital Tenon, AP HP, Paris, France
    Int J Radiat Oncol Biol Phys 68:66-72. 2007
    ..To evaluate the cosmetic results of sequential vs. concurrent adjuvant chemotherapy with radiotherapy after breast-conserving surgery for breast cancer, and to compare ratings by patients and physicians...